Published in Anti-Infectives Week, April 12th, 2004
The urgent need for novel strategies to block HIV-1 transmission is being recognized by an Europe-wide consortium, the European Microbicides Project (EMPRO), led by King's College London and funded by the European Commission.
The project aims to develop new microbicides containing molecules that block the virus' ability to attach itself to the genital mucosal surfaces. With HIV infection soaring and the absence of a protective vaccine, these products are urgently needed.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.